Potential of the Novel PTA Score to Identify Patients with Peritonsillar Inflammation Profiting from Medical Treatment

Disease Markers
Christoph SpiekermannClaudia Rudack

Abstract

Peritonsillar inflammation is a common characteristic of both peritonsillar abscess (PTA) and peritonsillitis (PC). The aim of the present study was to apply the PTA score as an objective criterion to identify patients with peritonsillar inflammation (PI) who might profit from medical treatment. Hence, the recently developed PTA score was applied retrospectively on patients suffering from acute tonsillitis, peritonsillitis, and peritonsillar abscess. Analysis of the clinical data, the follow-up, and the initial PTA score was performed. Patients with peritonsillar inflammation show significant higher PTA score values compared to patients with acute tonsillitis without peritonsillar inflammation and healthy controls. Patients with a PTA score ≤ 2 profited from medical treatment consisting of antibiotics in 92.3% of the cases. In 89.2% of the patients with a PTA score > 2, pus was detected during abscess relief. Patients with peritonsillar inflammation who profited from medical treatment had significantly reduced PTA score values and a reduced duration of hospitalization compared to the patients with abscess relief. Thus, the PTA score has the potential as an objective criterion to identify patients with peritonsillar inflammation...Continue Reading

References

Jun 1, 1988·Archives of Otolaryngology--head & Neck Surgery·D OphirG Marshak
Jun 22, 2000·International Archives of Allergy and Immunology·M J van KempenP B Van Cauwenberge
Sep 8, 2000·Journal of the American Society for Mass Spectrometry·K StrupatT Vogl
May 24, 2005·Current Opinion in Otolaryngology & Head and Neck Surgery·Romaine F Johnson, Michael G Stewart
May 25, 2005·International Journal of Pediatric Otorhinolaryngology·Anna KomorowskaHenryk Tchórzewski
Nov 9, 2005·Otolaryngology--head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery·Roland GigerPavel Dulguerov
Apr 29, 2006·Current Infectious Disease Reports·Fred S Herzon, Angela D Martin
Feb 28, 2008·Clinical Otolaryngology : Official Journal of ENT-UK ; Official Journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery·C Al YaghchiJ Harcourt
Feb 11, 2012·Clinical Otolaryngology : Official Journal of ENT-UK ; Official Journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery·J Powell, J A Wilson
Jun 24, 2016·Clinical and Experimental Otorhinolaryngology·Yu-Hsi LiuPi-Hsiung Wu
Dec 24, 2016·The Cochrane Database of Systematic Reviews·Brent A ChangDesmond A Nunez
Feb 9, 2017·Current Opinion in Otolaryngology & Head and Neck Surgery·Michael H FroehlichBrian K Reilly

❮ Previous
Next ❯

Methods Mentioned

BETA
ELISA
enzyme-linked

Software Mentioned

SPSS® Statistics
SigmaPlot®

Related Concepts

Related Feeds

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Related Papers

Srpski arhiv za celokupno lekarstvo
M Radovanović, D Radonjić
Otolaryngologia polska. The Polish otolaryngology
J BEUTLER-SZYMANSKA
Medizinische Monatsschrift
R SEEBOHM
© 2022 Meta ULC. All rights reserved